Pharmacogenetics of Drug Metabolizing Enzymes and Transporters: Effects on Pharmacokinetics and Pharmacodynamics of Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 8, 2010-10 ,pp. : 583-592

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-22 genetic polymorphisms and risk of colon cancer

By Thompson Cheryl   Plummer Sarah   Tucker Thomas   Casey Graham   Li Li  

Cancer Causes and Control, Vol. 21, Iss. 8, 2010-08 ,pp. : 1165-1170

Springer Publishing Company

Access to resources Recommend Favorite

Genetic polymorphisms of XPD and CDA and lung cancer risk

By          

Oncology Letters, Vol. 4, Iss. 2, 2012-01 ,pp. : 247-251

Spandidos Publications

Access to resources Recommend Favorite

Antihypertensive Drug Use and The Risk of Prostate Cancer (Canada)

By Perron Linda  

Cancer Causes and Control, Vol. 15, Iss. 6, 2004-08 ,pp. : 535-541

Springer Publishing Company

Access to resources Recommend Favorite

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

By Chen Hongmin   Wang Li   Beretov Julia   Hao Jingli   Xiao Weiwei   Li Yong  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 557-569

Springer Publishing Company

Access to resources Recommend Favorite